Federal Register / Vol. 78, No. 59 / Wednesday, March 27, 2013 / Notices 18601 

For Form 2: Antimicrobial 

Susceptibility Testing, the annual 

frequency of responses per respondent 

is 1,452 (121 isolates × 12 months). 

Based on previous laboratory 

experience, the estimated burden of 

completing Form 2 for each 

participating laboratory is 1 hour per 

response, which includes the time 

required for laboratory processing of the 

patient’s isolate, gathering and 

maintaining the data needed, and 

completing and reviewing the collection 

of information. For Form 3: Control 

Strain Susceptibility Testing, a 

‘‘response’’ is defined as the processing 

and recording of Regional laboratory 

data for a set of seven control strains. It 

takes approximately 12 minutes to 

process and record the Regional 

laboratory data on Form 3 for one set of 

seven control strains, of which there are 

4 sets. The number of responses per 

respondent is 48 (4 sets × 12 months). 

There are no additional costs to 

respondents. 

ESTIMATE OF ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Avg. burden 

per response 

(in hours) 

Total annual 

burden 

(in hours) 

Clinic .............................. Demographic Clinical Data Form 1 ..................... 30 240 11/60 1,320 

Laboratory ...................... Antimicrobial Susceptibility Testing Form 2 ........ 5 1,452 1 7,260 

Control Strain Susceptibility Testing Form 3 ....... 5 48 12/60 48 

Total ........................ .............................................................................. 40 ........................ ........................ 8,628 

Dated: March 21, 2013. 

Ron A. Otten, 

Director, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–07059 Filed 3–26–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Breast Cancer 

in Young Women (ACBCYW) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 9:00 a.m.–11:00 a.m. 

EDT, April 16, 2013. 

Place: The meeting will be held via 

teleconference. 

Teleconference login information is as 

follows: For Public: 

TOLL–FREE PHONE #: 800–857–4875 

Participant passcode: 9377 

Net Conference URL: https:// 

www.mymeetings.com/nc/join/ 

Conference number: PW8921926 

Audience passcode: 9377 or Public 

can join the event directly: https:// 

www.mymeetings.com/nc/ 

join.php?i=PW8921926&p=9377&t=c 

There is also a toll number for anyone 

outside of the USA: 

TOLL #: 1–212–287–1661 

Participant passcode: 9377 

Please go to the ACBCYW meeting 

Web page to register for this meeting: 

http://www.cdc.gov/cancer/breast/ 

what_cdc_is_doing/conference.htm. 

Status: Open to the public, limited 

only by the number of phone lines 

available. 

Purpose: The committee provides 

advice and guidance to the Secretary, 

HHS; the Assistant Secretary for Health; 

and the Director, CDC, regarding the 

formative research, development, 

implementation and evaluation of 

evidence-based activities designed to 

prevent breast cancer (particularly 

among those at heightened risk) and 

promote the early detection and support 

of young women who develop the 

disease. The advice provided by the 

Committee will assist in ensuring 

scientific quality, timeliness, utility, and 

dissemination of credible appropriate 

messages and resource materials. 

Matters To Be Discussed: The agenda 

will include discussions on approaches 

to increase awareness of clinicians/ 

practitioners regarding topics such as 

breast health, symptoms, diagnosis, and 

treatment of breast cancer in young 

women; and information needs and 

delivery mechanisms for women at 

higher risks for developing breast 

cancer. These discussions will be 

directed toward the final review and 

approval of formal recommendations on 

these topics. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Temeika L. Fairley, Ph.D., Designated 

Federal Officer, National Center for 

Chronic Disease Prevention and Health 

Promotion, CDC, 4770 Buford Highway 

NE., Mailstop K52, Atlanta, Georgia, 

30341, Telephone (770) 488–4518, Fax 

(770) 488–4760, Email: 

acbcyw@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and Agency for Toxic 

Substances and Disease Registry. 

Dana Redford, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–06946 Filed 3–26–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Respirator Certification Fees; Public 

Meeting 

AGENCY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of public meeting. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) 

announces a public meeting. The 

purpose of this meeting is to allow 

stakeholders to present information the 

impact of an increase on respirator fees 

on individual respirator manufacturers, 

the respirator market, or on those 

industries that rely on NIOSH approved 

respiratory equipment. 

DATES: April 30, 2013, 10 a.m. to 4 p.m. 

EDT, or after the last public commenter 

has spoken, whichever occurs first. 

ADDRESSES: U.S. Office of Surface 

Mining, Three Parkway Center 

mstockstill on DSK4VPTVN1PROD with NOTICES

18602 Federal Register / Vol. 78, No. 59 / Wednesday, March 27, 2013 / Notices 

(Greentree), Pittsburgh, PA 15220. This 

meeting will also be available by remote 

access. Registration information is 

available on the NIOSH Web site at 

http://www.cdc.gov/niosh. 

FOR FURTHER INFORMATION CONTACT: 

David Book, NIOSH National Personal 

Protective Technology Laboratory 

(NPPTL), 626 Cochrans Mill Road, 

Pittsburgh, PA 15236 (412) 386–6691 or 

(412) 386–5200 (these are not toll free 

numbers). 

SUPPLEMENTARY INFORMATION: 

Public Meeting 

NIOSH will hold a public meeting to 

allow commenters to present 

information on an increase in respirator 

certification and approval fees on 

individual respirator manufacturers, the 

respirator market, or on those industries 

that rely on NIOSH approved 

respiratory equipment. 

Requests to make presentations at the 

public meeting should be mailed to the 

NIOSH Docket Office, Robert A. Taft 

Laboratories, MS–C34, 4676 Columbia 

Parkway, Cincinnati, OH 45226. 

Requests may also be submitted by 

telephone (513) 533–8611, facsimile 

(513) 533–8285, or emailed to 

nioshdocket@cdc.gov with the words 

‘‘respirator fees presentation’’ in the 

subject line. All requests to present 

should contain the name, address, 

telephone number and relevant business 

affiliations of the presenter, and the 

approximate time requested for the 

presentation. Oral presentations will be 

limited to 15 minutes. After reviewing 

the requests for presentations, NIOSH 

will notify the presenter that his/her 

presentation is scheduled. If a 

participant is not in attendance when 

his/her presentation is scheduled to 

begin, the remaining participants will be 

heard in order. After the last scheduled 

speaker is heard, participants who 

missed their assigned times may be 

allowed to speak, limited by time 

available. 

Attendees who wish to speak but did 

not submit a request for the opportunity 

to make a presentation may be given 

this opportunity after the scheduled 

speakers are heard, at the discretion of 

the presiding officer and limited by time 

available. This meeting will also be 

using audio/LiveMeeting Conferencing, 

remote access capabilities where 

interested parties may listen in and 

view the presentations over the Internet 

simultaneously. Parties remotely 

accessing the meeting will have the 

opportunity to comment during the 

open comment period. 

Registration is required for both inperson and LiveMeeting participation. 

Because this meeting is being held at a 

Federal site, pre-registration is required 

on or before April 26, 2013 and a 

government-issued photo ID (driver’s 

license or passport) will be required to 

obtain entrance to the facility. Non-US 

citizens need to register by March 29, to 

allow sufficient time for mandatory 

facility security clearance procedures to 

be completed. 

An email confirming registration will 

be sent from NIOSH for both in-person 

participation and audio conferencing 

participation. Details required to 

participate via the conferencing will be 

provided by NIOSH in a separate email. 

This option will be available to 

participants on a first come, first served 

basis and is limited to the first 100 

participants. 

Registration information is available 

on the NIOSH Web site at http:// 

www.cdc.gov/niosh. 

Dated: March 20, 2013. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–06850 Filed 3–26–13; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee. 

Time and Date: 8:30 a.m.–3:00 p.m. 

(EDT), April 25, 2013. 

Place: CDC, Building 21, Rooms 1204 

A/B, 1600 Clifton Road, NE., Atlanta, 

Georgia 30333. 

Status: Open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 50 

people. The public is welcome to 

participate during the public comment 

period, which is tentatively scheduled 

from 2:45 p.m. to 2:50 p.m. This 

meeting is also available by 

teleconference. Please dial (877) 930– 

8819 and enter code 1579739. 

Purpose: The committee will provide 

advice to the CDC Director on strategic 

and other broad issues facing CDC. 

Matters To Be Discussed: The 

Advisory Committee to the Director will 

receive updates from the Global 

Workgroup; State, Tribal, Local and 

Territorial Workgroup; the 

Communications Workgroup; the Ethics 

Subcommittee, and the Health 

Disparities Subcommittee, as well as an 

update from the CDC Director. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Carmen Villar, M.S.W., Designated 

Federal Officer, Advisory Committee to 

the Director, CDC, 1600 Clifton Road 

NE., M/S D–14, Atlanta, Georgia 30333. 

Telephone 404/639–7000, Email: 

GHickman@cdc.gov. The deadline for 

notification of attendance is April 22, 

2013. To register for this meeting, please 

send an email to ACDirector@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dana Redford, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention (CDC). 

[FR Doc. 2013–06947 Filed 3–26–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[CFDA Number: 93.676] 

Announcement of the Award of Fifteen 

Single-Source Program Expansion 

Supplement Grants to Unaccompanied 

Alien Children’s Shelter Care Grantees 

AGENCY: Office of Refugee Resettlement, 

Administration for Children and 

Families, Department of Health and 

Human Services. 

ACTION: Announcement of the award of 

fifteen single-source program expansion 

grants to ten current grantees to expand 

bed capacity and supportive services to 

the increasing number of 

unaccompanied alien children. 

SUMMARY: The Administration for 

Children and Families (ACF), Office of 

Refugee Resettlement (ORR) announces 

the award of fifteen single-source 

program expansion supplement grants 

to the following ten current grantees, for 

a total of $47,168,490. 

mstockstill on DSK4VPTVN1PROD with NOTICES